The Knight ADRC has supported many investigators at Washington University and at other institutions over the years. We wish to avoid the situation where two investigators study the same research question to avoid duplication of effort and potential conflict. To determine if your topic has already been studied with our resources, please search our database. If you find that your topic or a related topic has been submitted, you may wish to contact the investigator to inquire about their findings to determine how you might proceed. You may wish to collaborate or modify your request to avoid overlap. The results below reflect requests made since online requests have been accepted. As such, not all fields will have data as certain information, such as aims, were not collected until recently. If an entry has been assigned an ID number (e.g. T1004), the full request has been submitted and is either approved, disapproved or in process. If an entry has no ID number, then it represents a submission that has not yet been reviewed. Search terms are applied across an entire requests application including variables not displayed below. A more specific, detailed search may yield better results depending upon your needs.
Search Terms:
Investigator: CAMD consortium
Project Title: CAMD request for biomarker data
Date: December 21, 2021 at 5:18 pm
Request ID: D1319
Aim 1: FDA biomarker qualification
Aim 2: Alzheimer’s disease progression modeling
Aim 3:
Aim 4:
Investigator: GS Day
Project Title: Evaluating the impact of medications in Alzheimer disease
Date: December 21, 2021 at 5:18 pm
Request ID: D1513
Aim 1: 1. Determine whether medications previously associated with cognitive impairment (i.e., offending medications) in cognitively normal individuals, associate with cognitive impairment in Memory and Aging Participants.
Aim 2: 2. Calculate the magnitude of effect of offending medication on participants with normal cognition, preclinical Alzheimer disease (AD) and symptomatic AD.
Aim 3:
Aim 4:
Investigator: Brian Gordon
Project Title: Sleep effects on amyloid deposition in preclinical AD
Date: December 21, 2021 at 5:18 pm
Request ID: D1512
Aim 1: Sleep quantity and quality to levels of amyloid deposition measured with PET and may be associated with structural atrophy
Aim 2: Sleep measures will predict baseline performance on psychometric testing
Aim 3: Use baseline measures of sleep will predict longitudinal amyloid, atrophy, and cognition
Aim 4:
Investigator: John C. Morris
Project Title: Examining the Relationship Between Depressive Symptoms and Cognitive Deficits in Preclinical Dementia of the Alzheimer Type
Date: December 21, 2021 at 5:18 pm
Request ID: D1511
Aim 1: Examine results from a psychometric battery of cognitive tests for patients with no evidience of clinical dementia
Aim 2: Asses the relationship between depression and preclinical AD through CSF samples analyzed for AD markers and PIB-PET amyloid imaging.
Aim 3: Compare antidepressive medication usage (e.g. SSRIs) to imaging data to assess the effect of medication usage on amyloid buildup.
Aim 4: To understand if those with depression and higher amyloid burden have worse cognitive performance.
Investigator: hugo vanderstichele
Project Title: CSF Biomarker analysis for to the Adult Children Study (ACS) of the Knight Alzheimer�s Disease Research Center at Washington (recently published by JAMA NEUROLOGY)
Date: December 21, 2021 at 5:18 pm
Request ID: D1510
Aim 1: AD CSF biomarker changes in cognitively normal middle-aged adults
Aim 2: Performance of individual biomarkers or combinations of biomarkers
Aim 3: Comparison of biomarkers with imaging data
Aim 4: Evaluate correlation between CSF biomarkers and cognitive performance
Investigator: Catherine Roe
Project Title: Pilot data for Sleep Aim of Preclinical AD and Driving Continuing Renewal
Date: December 21, 2021 at 5:18 pm
Request ID: D1509
Aim 1: To combine data from HASD Project 2 (Sleep study) with data from R01 AG043434-01 (Preclinical AD and Driving) for pilot data to be used in the R01 Continuing Renewal application.
Aim 2:
Aim 3:
Aim 4:
Investigator: Joan Montaner
Project Title: A NEW CHEMOKINE (CCL23) TO PREDICT MILD COGNITIVE IMPAIRMENT PROGRESSION TO ALZHEIMER DISEASE
Date: December 21, 2021 at 5:18 pm
Request ID: D1508
Aim 1: We aimed to evaluate the predictive value of CCL23 in patients with mild cognitive impairment that would develop dementia
Aim 2:
Aim 3:
Aim 4:
Investigator: Flemming Andersen
Project Title: PET/MR brain AC evaluation
Date: December 21, 2021 at 5:18 pm
Request ID: D1506
Aim 1: To evaluate promising PET/MR brain attenuation methods
Aim 2:
Aim 3:
Aim 4:
Investigator: Julia Soscia
Project Title: An item-level analysis of frequently missed items on the Mini Mental State Exam (MMSE) in cognitively normal older adults and its relationship to future cognitive impairment.
Date: December 21, 2021 at 5:18 pm
Request ID: D1505
Aim 1: To determine which MMSE items predict future cognitive problems
Aim 2:
Aim 3:
Aim 4:
Investigator: Yvette Sheline
Project Title: Comparison of graph characteristics in resting state fMRI in LOAD and DIAN participants
Date: December 21, 2021 at 5:18 pm
Request ID: D1504
Aim 1: Determine graph characteristics (wavelet-based coherence, binary graph diagnostics, weighted and cynamic graph diagnostics in LOAD and DIAN
Aim 2: Determine similarities and differences in these graph characteristics
Aim 3:
Aim 4: